PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
27-Jun-2022 CD Formulation Enables Customized Synthesis Service for Osmotic Pressure Regulators CD Formulation
27-Jun-2022 Aldehyde-functionalized Pheromone for Pest Management and Insect Trace Tracking Alfa Chemistry
27-Jun-2022 Alfa Chemistry Materials Launches Fuel Cell Catalysts for Renewable Energy Industry Alfa Chemistry
27-Jun-2022 Alfa Chemistry Releases Chemical Fluorophores for Bioanalysis, Environmental Monitoring, Clinical Diagnosis and Fluorescence Staining Alfa Chemistry
25-Jun-2022 Creative Enzymes Introduces DNA Modifying Enzymes for Molecular Biology Research Creative Enzymes
25-Jun-2022 Creative Enzymes Expands Its Service Offering with the Launch of Native Horseradish Peroxidase Creative Enzymes
24-Jun-2022 Global Ophthalmic Devices market is projected to grow at a CAGR of 4.76% By 2032: Visiongain Reports Ltd Visiongain Reports Limited
24-Jun-2022 PervasID to Present Solution for Tracking Medical Equipment and Surgical Instruments at Electronic and Biomedical Engineering Expo 2022 PervasID
24-Jun-2022 BRIM Biotechnology enters OTC trading in Taiwan BRIM Biotechnology
24-Jun-2022 argenx Receives Positive CHMP Opinion for Efgartigimod for the Treatment of Adult Patients with Generalized Myasthenia Gravis in Europe argenx
23-Jun-2022 Nanotechnology in Drug Delivery Market Report 2022-2032 Visiongain Reports Limited
23-Jun-2022 Novotech Receives CRO Leadership Award for Exceeding Customer Expectations Novotech Health Holdings Pte Ltd
23-Jun-2022 Creative Peptides Unveils Product Portfolio of Standard Fmoc/Boc-PNA Monomers Creative Peptides
22-Jun-2022 Carthera receives FDA Breakthrough Device Designation for SonoCloud-9 System Andrew Lloyd Associates
21-Jun-2022 VIVEbiotech continues the expansion of its lentiviral vector manufacturing capabilities to address the viral vector bottleneck VIVEbiotech
21-Jun-2022 New agreement paves way for development of first African-owned COVID-19 vaccine Afrigen Biologics & Univercells
21-Jun-2022 Alnylam UK and Refugee Action Launch 3-year Corporate ‘Challengers’ Partnership Aimed at Preparing More Refugees for Employment in the UK Alnylam Pharmaceuticals
21-Jun-2022 Major shareholder announcement for Genmab A/S Genmab A/S
21-Jun-2022 Naobios delivers FluGen Inc’s M2SR influenza vaccine candidate for upcoming clinical trials Andrew Lloyd Associates
21-Jun-2022 Therapeutic Respiratory Devices Market Report 2021-2031 Visiongain Reports Limited